Memantine

Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine is clinically used for the treatment of moderate to severe senile dementia and parkinsonism syndrome. It is a new type of anti-senile dementia drug and can be used for the treatment of moderate to severe senile dementia.

Memantine is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE (acetylcholinesterase) inhibitors.One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia.

Memantine has been associated with a modest improvement; with small positive effects on cognition, mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease. There does not appear to be any benefit in mild disease.

Memantine when added to donepezil in those with moderate-to-severe dementia resulted in "limited improvements" in a 2017 review. The UK National Institute of Clinical Excellence (NICE) issued guidance in 2018 recommending consideration of the combination of memantine with donepezil in those with moderate-to-severe dementia. Effects in autism are unclear. Recent scientific journal reports are showing guarded promise with severe obsessive compulsive disorder.

Mae gennym lawer o ffatrïoedd o ansawdd uchel gyda chydweithrediad dwfn, a all ddarparu cynhyrchion o ansawdd uchel a phrisiau cystadleuol i chi. A gallwn hefyd roi gostyngiadau ar gyfer swmp-brynu. Mae amser dosbarthu tua 3-20 diwrnod ar ôl cadarnhad taliad.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.
The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.
Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).
Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other. 

1. Ydych chi'n ffatri neu'n gwmni masnachu?
Rydym yn gwmni sy'n integreiddio diwydiant a masnach, yn darparu gwasanaeth un-stop. Gellid derbyn OEM.

2. A ydych chi'n darparu samplau? A yw'n rhad ac am ddim neu'n ychwanegol?
Samplau am ddim. Mae angen talu ffi cludo nwyddau'r sampl gan eich ochr chi.

3. A oes gennych unrhyw dystysgrifau sy'n ymwneud â rheoli ansawdd?
Ardystiad ISO 9001: 2008 i sicrhau ansawdd.

4. Beth ddylwn i ei ddarparu i gael dyfynbris?
Mae Pls yn rhoi gwybod i ni am y math o gynnyrch sydd ei angen arnoch, archebwch faint, cyfeiriad a gofynion penodol. Bydd y dyfynbris yn cael ei wneud ar gyfer eich cyfeirnod mewn pryd.

5. Pa fath o ddull talu sydd orau gennych chi? Pa fath o delerau sy'n cael eu derbyn?
Telerau Cyflwyno a Dderbynnir: FOB, CFR, CIF, EXW;
Arian Talu a Dderbynnir: USD;
Math o Daliad a Dderbynnir: T / T, Western Union; Paypal, Sicrwydd Masnach.
Iaith a siaredir: Saesneg.